![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Thailand | Publication | March 2023
Thailand's National Energy Policy Council has approved an increase in renewable energy power generating capacity from 9,996 MW to 12,700 MW to meet rising electricity demand. The council has approved a new procurement scheme, which includes 3,668.5 MW of total capacity from ground-mounted solar farms (2,632 MW), wind energy (1,000 MW), bio-gas (6.5 MW), and industrial waste (30 MW).
The relevant power purchase agreement will be non-firm, with a project life of up to 20-25 years. The Energy Regulatory Commission will launch the new scheme after the procurement under the previous program is completed (i.e. tentatively on or around 19 April 2023). This move is expected to attract significant investments and create job opportunities, while demonstrating Thailand's commitment to achieving carbon neutrality and net-zero carbon emissions by 2050 and 2065, respectively.
Our team at Norton Rose Fulbright will keep monitoring this matter for more updates.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023